T
Thymosin Alpha-1
Elite ResearchThymosin Alpha-1 is a naturally occurring peptide composed of 28 amino acids, derived from prothymosin alpha in the thymus gland, a key organ for immune system development
Uses
Chronic hepatitis B and C: Enhances immune response to clear viral infections
Immune deficiencies: Supports patients with compromised immunity
Cancer: Used as an adjunct therapy for cancers like melanoma, hepatocellular carcinoma, and non-small cell lung cancer, enhancing immune recognition of cancer cells
Infections: Studied for bacterial fungal, and viral infections
Vaccine enhancement: Boosts immune response to vaccines, improving efficacy, particularly for inactivated vaccines
Autoimmune diseases: Investigated for conditions like psoriatic arthritis and rheumatoid arthritis to restore immune balance
Research application
Copied from the handbook as research notes. and not instructions.
- 800mcg = 16 units
- 1600mcg = 32 units
- 3200mcg = 64 units
- Lower Dose Regimen: 800mcg 1-2x a week
- Standard Dose Regimen: 1600mcg 2x a week
Can be used for 6-12 months
Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes
From @BowTiedYukon